SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-186650
Filing Date
2021-06-09
Accepted
2021-06-09 15:43:29
Documents
4
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d185150dsc13d.htm SC 13D 96743
2 EX-99.1 d185150dex991.htm EX-99.1 31362
3 EX-99.3 d185150dex993.htm EX-99.3 7412
4 EX-99.4 d185150dex994.htm EX-99.4 8024
  Complete submission text file 0001193125-21-186650.txt   145393
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92582 | Film No.: 211004973
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019 212-247-6400
AI Day1 LLC (Filed by) CIK: 0001863302 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D